Three definitions of the metabolic syndrome: Relations to mortality and atherosclerotic morbidity

Metabolic Syndrome and Related Disorders

Volumn 3, Issue 2, 2005, Pages 102-112

  Larsson, Ingrid ^a   Lindroos, Anna Karin ^a   Lystig, Theodore C ^a,b   Näslund, Ingmar ^c   Sjöström, Lars ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE INTOLERANCE; HUMAN; INCIDENCE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; PERIPHERAL VASCULAR DISEASE; PREDICTION; PRIORITY JOURNAL; REGISTER; SWEDEN;

EID: 24644492408     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2005.3.102     Document Type: Article

References (26)

1. Krotkiewski M, Björntorp P, Sjöström L, et al. Impact of obesity on metabolism in men and women - importance of regional adipose tissue distribution. J Clin Invest 1983;72:1150-1162.
2. Larsson B, Svärdsudd K, Welin L, et al. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) 1984;288:1401-1404.
3. Lapidus L, Bengtsson C, Larsson B, et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 1984;289:1257-1261.
4. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
5. Zimmet PZ. Kelly West Lecture 1991. Challenges in diabetes epidemiology - from West to the rest. Diabetes Care 1992;15:232-252.
6. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:1514-1520.
7. Hanefeld M, Leonhardt W. Das metabolische syndrom. Dt Gesundh Wesen 1981;36:545-551.
8. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-194.
9. Björntorp P. Visceral obesity: a "civilization syndrome." Obes Res 1993;1:206-222.
10. WHO. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization (WHO) Department of Noncommunicable Disease Surveillance, 1999.
11. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
12. Balkau B, Charles MA, Drivsholm T, et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002;28:364-376.
13. Sjöström L, Larsson B, Backman L, et al. Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord 1992;16:465-479.
14. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-2693.
15. Larsson I, Berteus Forslund H, Lindroos AK, et al. Body composition in the SOS (Swedish Obese Subjects) reference study. Int J Obes Relat Metab Disord 2004;28:1317-1324.
16. Larsson I, Lindroos AK, Peltonen M, et al. Potassium per kg fat-free mass and total body potassium: predictions from sex, age and athropometry. Am J Physiol Endocrinol Metab 2003;284:E416-E423.
17. Sjöström L, Lönn L, Chowdhury B, et al. The sagittal diameter is a valid marker of the visceral adipose tissue volume. In: Progress in Obesity Research: 7. Angel A, Anderson H, Bouchard C, et al., eds. London: John Libbey & Company, 1996:309-319.
18. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288:2709-2716.
19. Hu G, Qiao Q, Tuomilehto J, et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004;164: 1066-76.
20. Lorenzo C, Okoloise M, Williams K, et al. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003;26:3153-3159.
21. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
22. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003;26:575-581.
23. Laaksonen DE, Lakka HM, Niskanen LK, et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002;156:1070-1077.
24. Villegas R, Perry IJ, Creagh D, et al. Prevalence of the metabolic syndrome in middle-aged men and women. Diabetes Care 2003;26:3198-3199.
25. Torgerson JS, Lindroos AK, Sjöström CD, et al. Are elevated aminotransferases and decreased bilirubin additional characteristics of the metabolic syndrome? Obes Res 1997; 5:105-114.
26. Silventoinen K, Sans S, Tolonen H, et al. Trends in obesity and energy supply in the WHO MONICA Project. Int J Obes Relat Metab Disord 2004;28:710-718.